Professor Ian Yang
Professor

Ian Yang

Email: 
Phone: 
+61 7 3139 5050

Background

Professor Ian Yang is a Thoracic Physician and Director of Thoracic Medicine at The Prince Charles Hospital, and Head of the PCH-Northside Clinical Unit, School of Clinical Medicine, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Availability

Professor Ian Yang is:
Available for supervision

Fields of research

Biomedical and Clinical Sciences Cardiovascular medicine and haematology Clinical sciences Oncology and carcinogenesis Respiratory diseases

Qualifications

  • Bachelor (Honours) of Medicine Surgery, The University of Queensland
  • Postgraduate Diploma, University of Newcastle
  • Doctor of Philosophy, The University of Queensland
  • Asian Pacific Society of Respirology, Asian Pacific Society of Respirology
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians
  • The Thoracic Society of Australia and New Zealand, The Thoracic Society of Australia and New Zealand

Research interests

  • Clinical and translational research in chronic lung diseases

    Pathogenesis, diagnosis and treatment of chronic lung diseases, including COPD, asthma, lung cancer, mesothelioma and effects of air pollution

Research impacts

His clinical work is in the field of thoracic medicine, and his research team is studying gene-environmental interaction in COPD, asthma, lung cancer and air pollution. He is involved in the training of higher degree students in translational research into lung diseases.

He is a Chair of the National COPD Guidelines Committee of the Lung Foundation Australia, and a member of the COPD Coordinating Committee. He is Chair of the Medical Programs and Research Advisory Committee of the Asthma Foundation Queensland NSW.

Search Professor Ian Yang’s works on UQ eSpace

360 works between 1999 and 2025
All (360) Journal Article (265) Book Chapter (10) Conference Publication (84) Other Outputs (1)

41 - 60 of 360 works

2022

Journal Article

Residential greenspace and early childhood development and academic performance: a longitudinal analysis of Australian children aged 4–12 years

Ahmed, Salma M., Knibbs, Luke D., Moss, Katrina M., Mouly, Tafzila A., Yang, Ian A. and Mishra, Gita D. (2022). Residential greenspace and early childhood development and academic performance: a longitudinal analysis of Australian children aged 4–12 years. Science of The Total Environment, 833 155214, 155214. doi: 10.1016/j.scitotenv.2022.155214

Residential greenspace and early childhood development and academic performance: a longitudinal analysis of Australian children aged 4–12 years

2022

Journal Article

Ambient air pollution and acute respiratory infection in children aged under 5 years living in 35 developing countries

Odo, Daniel B., Yang, Ian A., Dey, Sagnik, Hammer, Melanie S., van Donkelaar, Aaron, Martin, Randall V., Dong, Guang-Hui, Yang, Bo-Yi, Hystad, Perry and Knibbs, Luke D. (2022). Ambient air pollution and acute respiratory infection in children aged under 5 years living in 35 developing countries. Environment International, 159 107019, 107019. doi: 10.1016/j.envint.2021.107019

Ambient air pollution and acute respiratory infection in children aged under 5 years living in 35 developing countries

2022

Journal Article

Maternal and childhood ambient air pollution exposure and mental health symptoms and psychomotor development in children: an Australian population-based longitudinal study

Ahmed, Salma M., Mishra, Gita D., Moss, Katrina M., Yang, Ian A., Lycett, Kate and Knibbs, Luke D. (2022). Maternal and childhood ambient air pollution exposure and mental health symptoms and psychomotor development in children: an Australian population-based longitudinal study. Environment International, 158 107003, 107003. doi: 10.1016/j.envint.2021.107003

Maternal and childhood ambient air pollution exposure and mental health symptoms and psychomotor development in children: an Australian population-based longitudinal study

2022

Journal Article

USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study

Tammemägi, Martin C, Ruparel, Mamta, Tremblay, Alain, Myers, Renelle, Mayo, John, Yee, John, Atkar-Khattra, Sukhinder, Yuan, Ren, Cressman, Sonya, English, John, Bedard, Eric, MacEachern, Paul, Burrowes, Paul, Quaife, Samantha L, Marshall, Henry, Yang, Ian, Bowman, Rayleen, Passmore, Linda, McWilliams, Annette, Brims, Fraser, Lim, Kuan Pin, Mo, Lin, Melsom, Stephen, Saffar, Bann, Teh, Mark, Sheehan, Ramon, Kuok, Yijin, Manser, Renee, Irving, Louis ... Lam, Stephen (2022). USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. The Lancet Oncology, 23 (1), 138-148. doi: 10.1016/S1470-2045(21)00590-8

USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study

2021

Journal Article

Germline ERBB3 mutation in familial non-small cell lung carcinoma: expanding ErbB’s role in oncogenesis

McInerney-Leo, Aideen M., Chew, Hui Yi, Inglis, Po-Ling, Leo, Paul J., Joseph, Shannon R., Cooper, Caroline L., Okano, Satomi, Hassall, Tim, Anderson, Lisa, Bowman, Rayleen V., Gattas, Michael, Harris, Jessica E., Marshall, Mhairi S., Shaw, Janet G., Wheeler, Lawrie, Yang, Ian A., Brown, Matthew A., Fong, Kwun M., Simpson, Fiona and Duncan, Emma L. (2021). Germline ERBB3 mutation in familial non-small cell lung carcinoma: expanding ErbB’s role in oncogenesis. Human Molecular Genetics, 30 (24), 2393-2401. doi: 10.1093/hmg/ddab172

Germline ERBB3 mutation in familial non-small cell lung carcinoma: expanding ErbB’s role in oncogenesis

2021

Journal Article

Behaviour change: the key to implementing evidence on COPD prevention, diagnosis and management

Yang, Ian A., McDonald, Christine F. and Francis, Jill J. (2021). Behaviour change: the key to implementing evidence on COPD prevention, diagnosis and management. Respirology, 26 (11), 1021-1023. doi: 10.1111/resp.14160

Behaviour change: the key to implementing evidence on COPD prevention, diagnosis and management

2021

Conference Publication

Long-term outcomes of 265,737 patients hospitalised with atrial fibrillation and atrial flutter from 2008 to 2015

Ngo, L., Woodman, R., Walters, T., Denman, R., Yang, I. and Ranasinghe, I. (2021). Long-term outcomes of 265,737 patients hospitalised with atrial fibrillation and atrial flutter from 2008 to 2015. OXFORD: OXFORD UNIV PRESS.

Long-term outcomes of 265,737 patients hospitalised with atrial fibrillation and atrial flutter from 2008 to 2015

2021

Journal Article

Long-term outcomes of 265,737 patients hospitalised with atrial fibrillation and atrial flutter from 2008 to 2015

Ngo, L, Woodman, R, Walters, T, Denman, R, Yang, I and Ranasinghe, I (2021). Long-term outcomes of 265,737 patients hospitalised with atrial fibrillation and atrial flutter from 2008 to 2015. European Heart Journal, 42 (S1). doi: 10.1093/eurheartj/ehab724.0294

Long-term outcomes of 265,737 patients hospitalised with atrial fibrillation and atrial flutter from 2008 to 2015

2021

Journal Article

Referral criteria to palliative care for patients with respiratory disease: a systematic review

Philip, Jennifer, Collins, Anna, Smallwood, Natasha, Chang, Yuchieh Kathryn, Mo, Li, Yang, Ian A., Corte, Tamera, McDonald, Christine F. and Hui, David (2021). Referral criteria to palliative care for patients with respiratory disease: a systematic review. The European respiratory journal, 58 (4) 2004307, 2004307. doi: 10.1183/13993003.04307-2020

Referral criteria to palliative care for patients with respiratory disease: a systematic review

2021

Book Chapter

Overview of lung cancer

Olive, Gerard N., Marshall, Henry M., Yang, Ian A., Bowman, Rayleen V. and Fong, Kwun M. (2021). Overview of lung cancer. Encyclopedia of respiratory medicine. (pp. 621-633) edited by Sam M. Janes. Amsterdam, Netherlands: Elsevier. doi: 10.1016/B978-0-08-102723-3.00031-7

Overview of lung cancer

2021

Book Chapter

Differential diagnosis of mediastinal masses

Semasinghe Bandaralage, S. P., Slader, Simon, Leong, S., Yang, I. A., Bowman, R. V. and Fong, Kwun M. (2021). Differential diagnosis of mediastinal masses. Encyclopedia of respiratory medicine. (pp. 729-742) Amsterdam, Netherlands: Elsevier. doi: 10.1016/B978-0-08-102723-3.00033-0

Differential diagnosis of mediastinal masses

2021

Book Chapter

Metastases from lung cancer

Goffinet, Céline, Marshall, H., Yang, Ian A., Bowman, R. V. and Fong, Kwun M. (2021). Metastases from lung cancer. Encyclopedia of respiratory medicine. (pp. 785-792) Amsterdam, Netherlands: Elsevier. doi: 10.1016/B978-0-08-102723-3.00049-4

Metastases from lung cancer

2021

Journal Article

E-cigarettes induce toxicity comparable to tobacco cigarettes in airway epithelium from patients with COPD

O'Farrell, Hannah E., Brown, Reece, Brown, Zac, Milijevic, Branka, Ristovski, Zoran D., Bowman, Rayleen V., Fong, Kwun M., Vaughan, Annalicia and Yang, Ian A. (2021). E-cigarettes induce toxicity comparable to tobacco cigarettes in airway epithelium from patients with COPD. Toxicology in Vitro, 75 105204, 105204. doi: 10.1016/j.tiv.2021.105204

E-cigarettes induce toxicity comparable to tobacco cigarettes in airway epithelium from patients with COPD

2021

Journal Article

Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD

Martin, Allison, Hancox, Robert J., Chang, Catherina L., Beasley, Richard, Wrobel, Jeremy, McDonald, Vanessa, Dobler, Claudia C., Yang, Ian A., Farah, Claude S., Cochrane, Belinda, Hillis, Graham S., Scowcroft, Caroline Polak, Aggarwal, Ashutosh, Di Tanna, Gian Luca, Balicki, Grace, Galgey, Shane and Jenkins, Christine (2021). Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD. BMJ Open, 11 (8) e053446, e053446. doi: 10.1136/bmjopen-2021-053446

Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD

2021

Journal Article

Women’s empowerment as a pathway to sustainable and modern energy for all: evidence from the Demographic and Health Surveys

Odo, Daniel Bogale, Yang, Ian A., Green, Donna and Knibbs, Luke D. (2021). Women’s empowerment as a pathway to sustainable and modern energy for all: evidence from the Demographic and Health Surveys. ISEE Conference Abstracts, 2021 (1). doi: 10.1289/isee.2021.o-lt-069

Women’s empowerment as a pathway to sustainable and modern energy for all: evidence from the Demographic and Health Surveys

2021

Conference Publication

Long-term outcomes of patients undergoing catheter ablation of atrial fibrillation: A bi-national cohort study

Hai Ngo, Linh Thi, Woodman, Richard, Denman, Russell A., Walters, Tomos E., Yang, Ian and Ranasinghe, Isuru (2021). Long-term outcomes of patients undergoing catheter ablation of atrial fibrillation: A bi-national cohort study. Heart Rhythm 2021, Boston, MA United States, 28-31July 2021. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.hrthm.2021.06.336

Long-term outcomes of patients undergoing catheter ablation of atrial fibrillation: A bi-national cohort study

2021

Journal Article

Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: An AMAZES substudy

Shukla, Shakti D, Taylor, Steven L, Gibson, Peter G, Barker, Daniel, Upham, John W, Yang, Ian A, Reynolds, Paul N, Hodge, Sandra, James, Alan L, Rogers, Geraint B and Simpson, Jodie L (2021). Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: An AMAZES substudy. Thorax, 76 (7), 733-736. doi: 10.1136/thoraxjnl-2020-216331

Add-on azithromycin reduces sputum cytokines in non-eosinophilic asthma: An AMAZES substudy

2021

Journal Article

Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment

Niessen, Natalie M., Gibson, Peter G., Baines, Katherine J., Barker, Daniel, Yang, Ian A., Upham, John W., Reynolds, Paul N., Hodge, Sandra, James, Alan L., Jenkins, Christine, Peters, Matthew J., Marks, Guy B., Baraket, Melissa, Simpson, Jodie L. and Fricker, Michael (2021). Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment. Allergy, 76 (7) all.14768, 2090-2101. doi: 10.1111/all.14768

Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment

2021

Journal Article

Plasma extracellular vesicle miRNAs can identify lung cancer, current smoking status, and stable COPD

O’Farrell, Hannah E., Bowman, Rayleen V., Fong, Kwun M. and Yang, Ian A. (2021). Plasma extracellular vesicle miRNAs can identify lung cancer, current smoking status, and stable COPD. International Journal of Molecular Sciences, 22 (11) 5803, 1-19. doi: 10.3390/ijms22115803

Plasma extracellular vesicle miRNAs can identify lung cancer, current smoking status, and stable COPD

2021

Journal Article

Postoperative adjuvant EGFR-TKIs for resected EGFR-mutant NSCLC-opportunities and obstacles

Parris, Brielle A., Leong, Steven, Marshall, Henry, Yang, Ian A., Bowman, Rayleen V. and Fong, Kwun M. (2021). Postoperative adjuvant EGFR-TKIs for resected EGFR-mutant NSCLC-opportunities and obstacles. Annals of Translational Medicine, 9 (7) 586, 1-5. doi: 10.21037/atm-2020-133

Postoperative adjuvant EGFR-TKIs for resected EGFR-mutant NSCLC-opportunities and obstacles

Current funding

  • 2025 - 2027
    Extracellular-vesicles derived RNA biomarkers of lung cancer in never-smokers for early cancer detection
    Prince Charles Hospital Foundation
    Open grant
  • 2024 - 2026
    Changes in the lung microbiome with use of inhaled steroids in chronic obstructive pulmonary disease (COPD)
    Prince Charles Hospital Foundation
    Open grant
  • 2024 - 2025
    Lung Cancer Screening in Queensland
    Cancer Council Queensland
    Open grant
  • 2023 - 2026
    'Max Up' Trial - Maximising uptake of lung cancer screening and smoking cessation outcomes
    NHMRC MRFF EMCR - Early to Mid-Career Researchers
    Open grant
  • 2023 - 2025
    Transforming the care of people living with chronic obstructive pulmonary disease (COPD) using digital health
    Prince Charles Hospital Foundation
    Open grant
  • 2022 - 2026
    Defining the role and therapeutic manipulation of the gut-lung axis in respiratory disease (NHMRC Synergy administered by University of Technology Sydney)
    University of Technology Sydney
    Open grant
  • 2021 - 2025
    ACRF Lung Cancer Screening CENTRE OF EXCELLENCE (LUSCE)
    Australian Cancer Research Foundation
    Open grant
  • 2021 - 2026
    Lung cancer screening for early detection
    NHMRC MRFF EPCDR - Improving Diagnosis in Cancers with Low Survival Rates
    Open grant
  • 2021 - 2025
    Activating primary care COPD patients with Multi-morbidity (APCOM) study (MRFF Primary Health Care Research Grant led by Bond University)
    Bond University
    Open grant

Past funding

  • 2024 - 2025
    Cassette printer replacement (TPCHF Equipment Grant)
    Prince Charles Hospital Foundation
    Open grant
  • 2021 - 2023
    Inflammatory changes in 'onion skin' tissue layers surrounding the tumour site in lung cancer
    Prince Charles Hospital Foundation
    Open grant
  • 2020 - 2021
    TapeStation 4150
    Prince Charles Hospital Foundation
    Open grant
  • 2019 - 2020
    Inflammatory and DNA damage mechanisms in response to e-cigarette aerosols in COPD/lung cancer primary human bronchial epithelial cells
    Prince Charles Hospital Foundation
    Open grant
  • 2018 - 2020
    Extracellular vesicles as a novel biomarker for chronic obstructive pulmonary disease (COPD)
    Prince Charles Hospital Foundation
    Open grant
  • 2018 - 2024
    Dietary fibre and short chain fatty acids as immune regulators in COPD: a potential novel therapy
    Prince Charles Hospital Foundation
    Open grant
  • 2018 - 2019
    Bringing Modern Genomics to the Management of Lung Cancer in Queensland ( QGHA grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2017 - 2019
    Clinical trial validation of a blood exosome-prognosticator in lung cancer
    Prince Charles Hospital Foundation
    Open grant
  • 2017 - 2019
    Detection of microbial pathogens using quantitative polymerase chain reaction (qPCR) in patients with acute exacerbations of COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2017 - 2021
    Testing the lung microbiome to predict risk of frequent exacerbations in COPD
    NHMRC Project Grant
    Open grant
  • 2016 - 2023
    ACRF Centre for Lung Cancer Early Detection
    Australian Cancer Research Foundation
    Open grant
  • 2016 - 2019
    Mobile health for COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2016
    Using the lung microbiome to predict response to continuous antibiotics in COPD
    Australian Respiratory Council
    Open grant
  • 2015 - 2017
    SoM Leaders Research Support for Head Northside Clinical School
    Mayne Bequest Fund
    Open grant
  • 2014 - 2017
    The lung microbiome in coexisting COPD and bronchiectasis
    Prince Charles Hospital Foundation
    Open grant
  • 2014 - 2015
    Electronic Snapshot for Outpatient Management of COPD (ESO-COPD)
    Australian Centre for Health Services Innovation
    Open grant
  • 2013 - 2014
    Improving outcomes for patients with lung cancer and malignant mesothelioma
    Cancer Bequest Fund
    Open grant
  • 2013 - 2017
    PhD Scholarship in lung cancer - Funded by the Lung Foundation Australia/Neville Bantoft Bequest, with the UQ Thoracic Research Centre
    PhD Scholarship in Lung Cancer funded by the Lung Foundation Australia/Neville Bantoft Bequest
    Open grant
  • 2012 - 2017
    Clinical Academic Fellowship - Thoracic Physician
    Clinical Academic Fellowships
    Open grant
  • 2012 - 2017
    NHMRC Career Development Fellowship (Level 2): Preventing complications of chronic obstructive pulmonary disease
    NHMRC Career Development Award
    Open grant
  • 2012 - 2013
    Cigarette smoke and age-related epigenetic changes in the lung
    Prince Charles Hospital Foundation
    Open grant
  • 2012 - 2014
    Fundamental study into the role of the organic fraction on the toxicity of combustion generated airborne particles (ARC Discovery Project led by QUT)
    Queensland University of Technology
    Open grant
  • 2011 - 2012
    The Clinical Utility of High Resolution Melt Analysis in Detecting EGFR Mutations in the Serum of NSCLC Patients
    Pfizer Australia Pty Limited
    Open grant
  • 2011
    Tissue Culture Facility for the UQ Thoracic Research Centre
    NHMRC Equipment Grant
    Open grant
  • 2010 - 2011
    Novel microRNAs in pulmonary neoplasia
    Queensland Health
    Open grant
  • 2009 - 2012
    Mayne Bequest Fund Research Support Award: Thoracic Research
    Mayne Bequest Fund
    Open grant
  • 2009 - 2017
    Low dose CT screening for lung cancer
    Queensland Health Smart Health Research Grant
    Open grant
  • 2009 - 2012
    Genome-wide association study of protective alleles in lung cancer and chronic obstructive pulmonary disease
    Cancer Council Queensland
    Open grant
  • 2009 - 2015
    The AMAZES Study: Asthma and Macrolides: the AZithromycin Efficacy and Safety study (NHMRC Project Grant administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2008 - 2012
    Genomics of environmental stress and lung damage
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007 - 2012
    Respiratory rehabilitation or self management for Chronic Obstructive Pulmonary Disease: what is the best management approach?
    Medical Benefits Fund of Australia Limited
    Open grant
  • 2007 - 2013
    Aberrant promoter methylation in lung cancer and smokers (TPCH)
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007 - 2011
    Preventing progression of COPD
    NHMRC Career Development Award
    Open grant
  • 2006
    Innate Immunity genes in COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2006
    Molecular pathways associated with the severity of COPD
    Prince Charles Hospital Foundation
    Open grant
  • 2006
    Slowing the Progression of Chronic Lung Disease
    Viertel Foundation (Sylvia and Charles Viertel)
    Open grant
  • 2006 - 2009
    The role of innate immunity genes in COPD
    NHMRC Project Grant
    Open grant
  • 2005 - 2006
    Innate immunity genes in asthma and allergy
    Asthma Foundation of Queensland
    Open grant

Availability

Professor Ian Yang is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Diagnosis and treatment of chronic obstructive pulmonary disease

    Improving approaches to the early diagnosis, monitoring and management of patients with COPD

  • Lung ageing

    Genetics and epigenetics of ageing in the lung

  • The lung's response to air pollution

    Gene-environment interaction in the lung's response to exposure to air pollutants

Supervision history

Current supervision

  • Doctor Philosophy

    Biomarkers of lung cancer

    Principal Advisor

    Other advisors: Professor Kwun Fong

  • Master Philosophy

    Elastin turnover in the lung microenvironment and its significance in Lung Repair and Non-Small Cell Lung Carcinoma (NSCLC)

    Principal Advisor

    Other advisors: Professor Kwun Fong

  • Master Philosophy

    Elastin turnover in the lung microenvironment and its significance in Lung Repair and Non-Small Cell Lung Carcinoma (NSCLC)

    Principal Advisor

  • Doctor Philosophy

    Blood biomarkers for lung cancer screening

    Associate Advisor

    Other advisors: Professor Kwun Fong, Associate Professor Henry Marshall

  • Master Philosophy

    A multivariable prediction model for osteoporotic fracture in a lung cancer screening cohort

    Associate Advisor

    Other advisors: Professor Kwun Fong, Associate Professor Henry Marshall

  • Doctor Philosophy

    Molecular drivers of lung cancer.

    Associate Advisor

  • Doctor Philosophy

    Randomised pragmatic trial of comprehensive tissue sampling enabled by ultrathin bronchoscopic Radial probe EndoBronchial Ultrasound versus CT-guided TransThoracic needle aspiration/biopsy (REBUTT) for evaluation of peripheral pulmonary lesions.

    Associate Advisor

    Other advisors: Professor Kwun Fong

  • Master Philosophy

    A multivariable prediction model for osteoporotic fracture and low bone density in a lung cancer screening cohort

    Associate Advisor

    Other advisors: Professor Kwun Fong, Associate Professor Henry Marshall

  • Doctor Philosophy

    Precision medicine in the genomic era: emerging technologies for molecular profiling of lung cancer

    Associate Advisor

    Other advisors: Professor Kwun Fong

Completed supervision

Enquiries

For media enquiries about Professor Ian Yang's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au